O'Brien JD & Burnham WRBleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area. British Medical Journal1985; 291: 1609-10.
2.
Somerville K. , Faulkner G. & Langman M.Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet1986; i: 462-4.
3.
Jick H., Feld AD & Perera DRCertain non-steroidal anti-inflammatory drugs and hospitalisation for upper gastrointestinal bleeding. Pharmacotherapy1985; 5: 280-4.
4.
Griffin JPSurvey of the spontaneous adverse drug reaction reporting schemes in 15 countries . British Journal of Clinical Pharmacology1986; 22: 83S-100S.
5.
Witts LJAdverse reactions to drugs. British Medical Journal1965; 2: 1081-6.
6.
Doll R.Unwanted effects of drugs. British MedicalBulletin1971; 27: 25-31.
7.
Inman Whw.Postmarketing surveillance in the general population: The United Kingdom. In Monitoring for Drug Safety, ed. WHW Inman.Lancaster, MTP Press , 1980.
8.
Idanpaan-Heikkila J., Alhava F., Olkinuora M. & Palva IPAgranulocytosis during treatment with clozapine . European Journal of Clinical Pharmacology1977; 10: 1-5.
9.
Committee on Safety of Medicines.Zimeldine. Current Problems, No. 11. 1982.
10.
Committee on Safety of Medicines Update.Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions (1). British Medical Journal1986; 292: 614.
11.
Committee on Safety of Medicines Update.Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions (2). British Medical Journal1986; 292: 1190-1.
12.
Fok KH, George Pjm & Vicary FRPeptic ulcers induced by piroxicam. British Medical Journal1985; 290: 117-8.
13.
Rossi AC, Hsu JP & Faich GAUlcerogenicity of piroxicam: an analysis of spontaneously reported data. British Medical Journal1987; 294: 147-50.
14.
Sachs RM & Bortnichak EAAn evaluation of spontaneous adverse drug reactions monitoring systems. American Journal of Medicine1986; 81 (suppl. 5B): 49-55.
15.
Bortnichak EA & Sachs RMPiroxicam in recent epidemiologic studies . American Journal of Medicine1986; 81 (suppl. 5B); 44-8.
16.
Meisel ADClinical benefits and comparative safety of piroxicam: analysis of world-wide clinical trials data. American Journal of Medicine1986; 81 (suppl. 5B) 15-21.
17.
Dollery CT & Rawlins MDMonitoring adverse reactions to new drugs. British Medical Journal1977; 1: 96-7.
18.
Lawson DH & Henry DAMonitoring adverse reactions to new drugs: restricted release or monitored release?British Medical Journal1977; 1: 691-2.
19.
Grahame-Smith DGReport of the Adverse Reaction Working Party to the Committee on Safety of Medicines. London: Department of Health & Social Security, 1986.
20.
CIOMS Working Group Report.Monitoring and Assessment of Adverse Drug Effects. Geneva : Council for International Organisations of Medical Sciences, 1986.
21.
Rawlins MDSpontaneous reporting of adverse drug reactions. Quarterly Journal of Medicine1986; 230: 531-4.
22.
Spiers CJ, Griffin JP, Weber Jcp, Glen-Bott M & Twomey C. Demography of the UK Adverse Reactions Register . Health Trends1984; 16: 49-52.
